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Introduction 
Ayurveda is one of the oldest healing system of 
medicines. Drug formulation in Ayurveda is mainly of 
two kinds- (i)use of sing drug (ii)use of combination of 
drugs (polyherbal formulation).The different types of 
formulations described in the field of Ayurveda include 
Choornas(fine powders), Kwathas (Aqueous extracts), 
Taila/Grithas (lipid extracts), Gutikas (tablets) to name 
a few(1-2). The methods of manufacture and protocols 
for standardization of formulations mentioned in the 
classical texts of Ayurveda are quite premature, hence in 
the present era, changing trends have necessitated the 
establishment of standards for Ayurvedic drugs & 
formulations and development of reliable quality 
protocols for Ayurvedic formulations using modern 
techniques of analysis is extremely important. 
Standardization is an important aspect in 
maintaining the quality and safety of any polyherbal 
formulation as these are combinations of more than a 
herb to attain the desired therapeutic effect and it also 
helps minimize batch to batch variation (3). A 
polyherbal Ayurvedic formulation (Trivrutadi gutika) 
was prepared using different drugs including 
Operculina turpethum Linn, Piper longum Linn. 
Terminalia chebula Retz. Saccharum officinarum 
according to the standard gutika/tablet preparation 
along with modern techniques of Tableting. The present 
study is an attempt to develop and standardize 
Trivrutadi gutika and to evaluate its efficacy in 
childhood constipation (functional in origin). To fulfil 
the requirement of the emerging trend, the prepared 
tablet was subjected for standardization as per 
pharmacopeial norms. 
Materials and Methods 
Collection of Raw drugs 
The materials for the formulation Trivrutadi 
gutika- Trivrut (Operculina turpethum Linn.), 
Pippali(Piper longum Linn.), Haritaki(Terminalia 
chebula Retz.), Guda(Saccharum officinarum) were 
procured and manufactured  by AVN Ayurveda 
Formulations Pvt.Ltd. Madurai, TamilNadu, India and 
was authenticated at the in house quality control 
department. The prepared tablet was then subjected for 
characterisation and HPTLC finger printing. 
Preparation of Trivrutadi Gutika 
The raw materials were procured and were 
checked for the quality by comparing their HPTLC 
profiles against an in-house standard. The different parts 
of the plant used for the preparation (Table 1) were then 
washed thoroughly with running water to remove all 
physical impurities (sand/mud) and dried for one day 
under sunlight. The dried ingredients along with 
Guda(Jaggery) was then powdered in a  blender and 
sieved using an electric sieve having 100 microgram 
mesh size separately. All the uniformly micronized 
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powders were then mixed. To this mixture, binding and 
disintegration agents (Aerosil 0.050kg, Magnesium 
stearate 0.010kg, Maize starch 0.940kg etc) were added. 
By using tablet punching machine, the powder is 
converted into tablets weighing 500mg each. 
Table 1: Part of the plant used in the preparation of 
formulation 
 
Analytical study of Trivrutadi gutika 
ORGANOLEPTIC EVALUATION 
1.COLOR- Blackish brown colour  
2.ODOUR- Characteristic odour 
3.TASTE- Astringent 
4.SIZE & SHAPE- Dimensionally, it is 20.0 mm length, 
9.30 mm width, 7.50 mm thickness which falls within + 
5% variation of the standard value. The shape of the 
tablet was – elongated bi-convex. 
PHYSICO-CHEMICAL ANALYSIS 
1. Twenty tablets were randomly selected and weighted 
individually on Shimadzu electronic analytical balance. 
The average weight was measured, and the percentage 
of deviation was calculated using the following 
formula. 
  
As per USP standards, individual weights of two tablets 
should not deviate from the average weight by 5% and 
none deviated by 10% (4). 
1.Hardness: Hardness is the measure of the mechanical 
integrity of the tablets. It is the force required to break 
the tablets in a specific plan. Tablet requires a certain 
amount of strength or hardness and resistance to 
withstand mechanical shakes of handling in 
manufacture, packaging and shipping. The randomly 
selected tablets were tested individually using Pfizer 
tablet hardness tester. The tablet was held vertically in 
between the jaws of hardness tester. The force applied 
to the edge of the pill was gradually increased by 
pressing the jaws with the help of hand until the tablet 
breaks. The reading was recorded, and the average 
hardness of each group was calculated separately. The 
reading is expressed as Kg/Cm2 or in Newton (N)(4). 
2. Friability: One of the commonly employed test to 
measure the ability of tablets to withstand mechanical 
stresses determines their resistance to chipping and 
surface abrasion by tumbling them in a rotating drum. 
The percentage weight loss after tumbling is referred to 
as the friability of the tablets. The friability test is 
conducted in the Roche friability apparatus by taking 20 
tablets. This consists of a plastic drum that revolves at 
25rpm, dropping the tablets through six inches in the 
friabilator to undergo shock, which is then operated for 
100 revolutions. The tablets are reweighed. The tablet 
that lose less than1.0% of the tablet weight are 
considered as acceptable (4). 
3. Loss on drying: This procedure determines the 
amount of volatile matter or water present in the drug. 
For a stable shelf life, the moisture content should be 
below 2%. The moisture present in the product is also 
known as water activity. Higher water activity is 
directly proportional to microbial growth such as yeast, 
mould and bacteria. The LOD is determined by 
moisture balance equipped with an infra-red lamp. To 
determine the LOD, about 2g of drug is kept on the 
moisture balance and dried at 1050C till getting a 
constant weight and weight between two consecutive 
time intervals is not more than 0.01g.   
4. Disintegrating time: Disintegration is defined as that 
state in which no residue of the tablet remains on the 
screen of apparatus. This test determines whether the 
tablet disintegrate within a prescribed time when placed 
in a liquid medium under the prescribed experimental 
conditions.  The tank of the disintegration apparatus 
was filled with distilled water up to the mark. 750 ml of 
distilled water in each of the 1000 ml beaker was taken. 
The timer of the instrument was set for 60 minutes. The 
temperature of water in beakers to 370C and that of 
water in the main tank to 370C was maintained. One 
tablet was introduced into each tube and added a disk to 
each tube. The assembly was suspended in the beaker 
containing water and the apparatus was operated. The 
time duration at which the tablet disintegrates was 
noted. As per set criteria by USP if 6 tablets are tested, 
all the 6 tablets should be disintegrated.   
5. Total ash: Two grams of coarse powdered air-dried 
material was accurately weighed in a previously 
activated and tarred silica crucible. The drug was 
gradually ignited by raising temperature to 4500 inside a 
muffle furnace, until it was white, indicating absence of 
carbon. The sample was cooled in a desiccator and 
weighed. The percentage of total ash was calculated 
with reference to air dried drug. A high ash value is 
indicative of contamination, substitution, adulteration, 
presence of silica, rice husk or carelessness in preparing 
the drug. 
Sl No Name of plant
Part used in the 
preparation
Proportio
n
1 Trivrut Moola (Root) 90 grams
2 Pippali Phala (Fruit) 180 grams
3 Haritaki Phala (Fruit) 230 grams
4 Guda ---- 500 grams
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6. Acid insoluble ash: The ash was boiled with 25 ml 
of 2 M hydrochloric acid for 5 minutes, the insoluble 
matter was collected on an ash less filter paper, washed 
with hot water till neutral pH, ignited, cooled in a 
desiccator, and weighed. The percentage of acid 
insoluble ash was calculated with reference to the air-
dried drug. A low acid-insoluble ash value affects the 
amount of the drug component absorbed in the 
gastrointestinal canal when taken orally. 
7. Water soluble ash: The ash was boiled with 25 ml of 
water for 5 minutes, the insoluble matter on ash less 
filter paper collected, washed with hot water, ignited, 
cooled in a desiccator, and weighed. The weight of the 
insoluble matter from the weight of the total ash was 
subtracted. The difference represents the water-soluble 
ash. The percentage of water insoluble ash was 
calculated with reference to the air-dried drug (5). 
8. pH: pH is determined by dissolving 2gm of tablet 
powder in 100 ml of de-mineralized water at room 
temperature.  
Table 2: Physico-Chemical Properties of Trivrutadi 
gutika 
HPTLC 
The above plant materials along with their 
corresponding formulation Trivrutadi gulika were 
extracted with alcohol based on their phytochemical 
composition. TLC was developed for all samples in an 
optimized solvent system of Toluene: Ethyl acetate: 
Methanol in an optimized composition of 7:2:1. 100mg/
ml of sample solution was prepared in methanol and 
filtered through the 0.45µm membrane filter. Each of 
sample was spotted at 10l volume, by Linomat 5 
applicator on pre-coated silica gel plate (silica gel-60 
F254)-Merck) from 1cm above the plate. 100µl capacity 
Hamilton® syringe was used for sample loading. TLC 
plate was run in the CAMAG TLC 10×10 chamber. 
Before running the TLC, the chamber was saturated 
with the solvent for 10 minutes with paper lining of the 
chamber. Then the TLC was run for 8 minutes from 
application band. In completion of the run the TLC was 
dried vertically and visualized in the UV chamber to 
check the resolution and analysed in CAMAG TLC 
scanner 3 and software win CATS 1.4.3 (6).  
PEAK DISPLAY 
TLC densitogram @ 254nm 
Parameter Observation Specification
Weight 1.016 gm ±5% of average weight
Hardness 9.0kg/cm2 NLT 10kg/cm2
Loss on drying 8.20% Not more than 10%
Disintegration 
time 45 minutes
Not more than 60 
minutes
Total ash 7.00% Not more than 20%±
Acid insoluble ash 2.96% Not more than 10%
Water soluble ash 3.40% Not more than 10%
pH 3.81 3.0 to 5.0
Friability 0.49% Not more than 1% w/w
Fingerprinting
254nm @366 nm
Figure 9 – Fingerprinting of Trivrutadi Gutika at  
245 & 366 nm
Visualization
Figure 10 Visualisation under 245 and 366 nm
Figure 11 - Terminalia 
chebula
Figure 12 - Operculina 
turpethum Figure 14 -   Piper longum Figure 15 - Trivrutadi Gutika
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TLC densitogram @ 366nm 
    
Table no 3: Showing the Rf value and Area at 254nm 
Table no 3: Showing the Rf value and Area at 366nm 
Results and discussion 
Visibly the TLC fingerprint of the Gutika 
showed presence of the bands from extracts of TC, OT 
and PL. Further both the above chromatogram and 
densitogram showed the overlapping bands of the all 
the individual constituents with that of the finished 
product formulation. The finished product Trivrutadi 
gutika-TG showed corresponding bands from 
Operculina turpethum-OT and Piper longum-PL at Rf 
of 0.11, 0.19 and 0.25 for OT and at 0.52 and 0.96 from 
PL. At 366 nm the bands from PL were more prominent 
at Rf 0.27, 0.33, 0.40, 0.45, 0.53 and 0.88 from PL with 
corresponding bands at 0.28, 0.34, 0.40 and 0.42, 0.54 
and 0.88 in the TG formulation. At 366 nm OT showed 
that bands at 0.88 which matches with the TG at the 
same Rf. The slight variation of the Rf value may be 
complexity of the formulation in TG and compound-
compound interaction with the TLC stationary phase. 
Therefore, above HPTLC study can be used as quality 
control parameter for study of the finished product 
formulation as well as to determine the authenticity and 
reliability of the chemical constituents or herbal 
constituents as mentioned in their label claim.   
Further all other parameters like uniformity of 
weight, loss on drying, disintegration time, friability, 
hardness, total ash, water soluble ash and acid insoluble 
ash were well within the norms specified by the Indian 
Ayurvedic Pharmacopeia with respect to a tablet. Hence 
it can be deduced that if the raw materials sourced are 
put under rigorous quality control and if there are strict 
in process controls in the manufacture of a formulation, 
the likelihood for batch to batch variation and 
production of an ineffective formulation is very 
meagre(7-9). 
Conclusion 
The raw materials required for the production 
of Trivrutadi gutika were characterised by HPTLC 
Figure 16 - Terminalia chebula Figure 17 - Operculina turpethum Figure 18 -   Piper longum Figure 19 - Trivrutadi Gutika
Peak @254nmRfValue Area (AUC)
Samples Terminalia chebula
Operculina 
turpethum
Piper 
longum
Trivrutadi 
gutika
Terminalia 
chebula
Operculina 
turpethum
Piper 
longum
Trivrutadi 
gutika
1 0.91 0.11 0.07 0.08 322.20 316.70 350.70 2078.70
2 0.19 0.28 0.16 1233.80 1294.30 234.70
3 0.25 0.35 0.29 842.30 1364.50 468.90
4 0.31 0.41 0.37 3400.80 3202.70 602.80
5 0.35 0.52 0.53 1693.60 11942.10 5330.20
6 0.45 0.56 0.82 975.30 1402.10 25414.30
7 0.53 0.61 0.96 900.70 671.30 1596.50
8 0.56 0.82 366.90 49460.40
9 0.79 0.960 405.10 8191.70
10 0.94 1186.80
Peak @366nmRfValue Area (AUC)
Samples Terminalia chebula
Operculina 
turpethum
Piper 
longum
Trivrutadi 
gutika
Terminalia 
chebula
Operculina 
turpethum
Piper 
longum
Trivrutadi 
gutika
1 0.18 0.20 0.09 0.09 995.10 373.80 176.40 1110.70
2 0.43 0.20 0.28 384.50 893.60 1931.60
3 0.46 0.27 0.34 1294.40 4158.80 1669.80
4 0.53 0.33 0.40 2665.60 3146.20 1737.50
5 0.88 0.38 0.42 2647.40 3277.70 2197.90
6 0.94 0.40 0.47 241.60 2616.20 1435.90
7 0.45 0.54 2557.60 749.50
8 0.53 0.88 1381.50 419.30
9 0.60 760.00
10 0.72 853.80
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fingerprinting and compared vis-à-vis an in-house 
standard and all the manufacturing steps were tightly 
controlled followed by characterization of the 
formulation as mentioned in the Indian Pharmacopeia. 
In addition to the characterization norms set in the 
Indian Pharmacopeia, HPTLC fingerprinting was done 
to compare and elicit the presence of the various actives 
of the raw-materials in the finished product, results of 
which suggest that several active ingredients present in 
the raw-materials are seen in the final formulation there 
by suggesting that the desired action of efficacy of the 
drug be ensured. 
The data thus obtained can be used to conclude 
that standardisation of the manufacturing process and 
standardisation of the raw materials will be helpful in 
reproducibility of formulations as well as to ensure the 
quality and safety of the formulations. 
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